The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Deep Brain Stimulation in Parkinson's Disease Market Research Report 2025
Synopsis
Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.
The global Deep Brain Stimulation in Parkinson's Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Deep Brain Stimulation in Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Deep Brain Stimulation in Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Deep Brain Stimulation in Parkinson's Disease in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Deep Brain Stimulation in Parkinson's Disease include Abbott, Aleva Neurotherapeutics SA, Beijing PINS Medical Co, Boston Scientific Corporation, Functional Neuromodulation Ltd, Medtronic, Neuronetics Inc., NeuroPace Inc. and Nevro Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Deep Brain Stimulation in Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deep Brain Stimulation in Parkinson's Disease.
Report Scope
The Deep Brain Stimulation in Parkinson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deep Brain Stimulation in Parkinson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deep Brain Stimulation in Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Aleva Neurotherapeutics SA
Beijing PINS Medical Co
Boston Scientific Corporation
Functional Neuromodulation Ltd
Medtronic
Neuronetics Inc.
NeuroPace Inc.
Nevro Corporation
Segment by Type
Dual Channel Deep brain Stimulator
Single Channel Deep brain Stimulator
Segment by Application
Hospitals
Neurology Clinics
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deep Brain Stimulation in Parkinson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.
The global Deep Brain Stimulation in Parkinson's Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Deep Brain Stimulation in Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Deep Brain Stimulation in Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Deep Brain Stimulation in Parkinson's Disease in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Deep Brain Stimulation in Parkinson's Disease include Abbott, Aleva Neurotherapeutics SA, Beijing PINS Medical Co, Boston Scientific Corporation, Functional Neuromodulation Ltd, Medtronic, Neuronetics Inc., NeuroPace Inc. and Nevro Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Deep Brain Stimulation in Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deep Brain Stimulation in Parkinson's Disease.
Report Scope
The Deep Brain Stimulation in Parkinson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deep Brain Stimulation in Parkinson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deep Brain Stimulation in Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Aleva Neurotherapeutics SA
Beijing PINS Medical Co
Boston Scientific Corporation
Functional Neuromodulation Ltd
Medtronic
Neuronetics Inc.
NeuroPace Inc.
Nevro Corporation
Segment by Type
Dual Channel Deep brain Stimulator
Single Channel Deep brain Stimulator
Segment by Application
Hospitals
Neurology Clinics
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Deep Brain Stimulation in Parkinson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Dual Channel Deep brain Stimulator
1.2.3 Single Channel Deep brain Stimulator
1.3 Market by Application
1.3.1 Global Deep Brain Stimulation in Parkinson's Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Neurology Clinics
1.3.4 Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Deep Brain Stimulation in Parkinson's Disease Market Perspective (2019-2030)
2.2 Deep Brain Stimulation in Parkinson's Disease Growth Trends by Region
2.2.1 Global Deep Brain Stimulation in Parkinson's Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Deep Brain Stimulation in Parkinson's Disease Historic Market Size by Region (2019-2024)
2.2.3 Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Region (2025-2030)
2.3 Deep Brain Stimulation in Parkinson's Disease Market Dynamics
2.3.1 Deep Brain Stimulation in Parkinson's Disease Industry Trends
2.3.2 Deep Brain Stimulation in Parkinson's Disease Market Drivers
2.3.3 Deep Brain Stimulation in Parkinson's Disease Market Challenges
2.3.4 Deep Brain Stimulation in Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Deep Brain Stimulation in Parkinson's Disease Players by Revenue
3.1.1 Global Top Deep Brain Stimulation in Parkinson's Disease Players by Revenue (2019-2024)
3.1.2 Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Deep Brain Stimulation in Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Deep Brain Stimulation in Parkinson's Disease Revenue
3.4 Global Deep Brain Stimulation in Parkinson's Disease Market Concentration Ratio
3.4.1 Global Deep Brain Stimulation in Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deep Brain Stimulation in Parkinson's Disease Revenue in 2023
3.5 Deep Brain Stimulation in Parkinson's Disease Key Players Head office and Area Served
3.6 Key Players Deep Brain Stimulation in Parkinson's Disease Product Solution and Service
3.7 Date of Enter into Deep Brain Stimulation in Parkinson's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Deep Brain Stimulation in Parkinson's Disease Breakdown Data by Type
4.1 Global Deep Brain Stimulation in Parkinson's Disease Historic Market Size by Type (2019-2024)
4.2 Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Type (2025-2030)
5 Deep Brain Stimulation in Parkinson's Disease Breakdown Data by Application
5.1 Global Deep Brain Stimulation in Parkinson's Disease Historic Market Size by Application (2019-2024)
5.2 Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Deep Brain Stimulation in Parkinson's Disease Market Size (2019-2030)
6.2 North America Deep Brain Stimulation in Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024)
6.4 North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Deep Brain Stimulation in Parkinson's Disease Market Size (2019-2030)
7.2 Europe Deep Brain Stimulation in Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024)
7.4 Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size (2019-2030)
8.2 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size (2019-2030)
9.2 Latin America Deep Brain Stimulation in Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024)
9.4 Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size (2019-2030)
10.2 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Deep Brain Stimulation in Parkinson's Disease Introduction
11.1.4 Abbott Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Aleva Neurotherapeutics SA
11.2.1 Aleva Neurotherapeutics SA Company Detail
11.2.2 Aleva Neurotherapeutics SA Business Overview
11.2.3 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Introduction
11.2.4 Aleva Neurotherapeutics SA Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.2.5 Aleva Neurotherapeutics SA Recent Development
11.3 Beijing PINS Medical Co
11.3.1 Beijing PINS Medical Co Company Detail
11.3.2 Beijing PINS Medical Co Business Overview
11.3.3 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Introduction
11.3.4 Beijing PINS Medical Co Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.3.5 Beijing PINS Medical Co Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Detail
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Introduction
11.4.4 Boston Scientific Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Functional Neuromodulation Ltd
11.5.1 Functional Neuromodulation Ltd Company Detail
11.5.2 Functional Neuromodulation Ltd Business Overview
11.5.3 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Introduction
11.5.4 Functional Neuromodulation Ltd Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.5.5 Functional Neuromodulation Ltd Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Deep Brain Stimulation in Parkinson's Disease Introduction
11.6.4 Medtronic Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Neuronetics Inc.
11.7.1 Neuronetics Inc. Company Detail
11.7.2 Neuronetics Inc. Business Overview
11.7.3 Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Introduction
11.7.4 Neuronetics Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.7.5 Neuronetics Inc. Recent Development
11.8 NeuroPace Inc.
11.8.1 NeuroPace Inc. Company Detail
11.8.2 NeuroPace Inc. Business Overview
11.8.3 NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Introduction
11.8.4 NeuroPace Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.8.5 NeuroPace Inc. Recent Development
11.9 Nevro Corporation
11.9.1 Nevro Corporation Company Detail
11.9.2 Nevro Corporation Business Overview
11.9.3 Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Introduction
11.9.4 Nevro Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
11.9.5 Nevro Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Dual Channel Deep brain Stimulator
Table 3. Key Players of Single Channel Deep brain Stimulator
Table 4. Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Region (2019-2024)
Table 8. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Region (2025-2030)
Table 10. Deep Brain Stimulation in Parkinson's Disease Market Trends
Table 11. Deep Brain Stimulation in Parkinson's Disease Market Drivers
Table 12. Deep Brain Stimulation in Parkinson's Disease Market Challenges
Table 13. Deep Brain Stimulation in Parkinson's Disease Market Restraints
Table 14. Global Deep Brain Stimulation in Parkinson's Disease Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Players (2019-2024)
Table 16. Global Top Deep Brain Stimulation in Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deep Brain Stimulation in Parkinson's Disease as of 2023)
Table 17. Ranking of Global Top Deep Brain Stimulation in Parkinson's Disease Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Deep Brain Stimulation in Parkinson's Disease Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Deep Brain Stimulation in Parkinson's Disease Product Solution and Service
Table 21. Date of Enter into Deep Brain Stimulation in Parkinson's Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2019-2024)
Table 25. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2025-2030)
Table 27. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Application (2019-2024)
Table 29. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Application (2025-2030)
Table 31. North America Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Deep Brain Stimulation in Parkinson's Disease Product
Table 49. Abbott Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Aleva Neurotherapeutics SA Company Detail
Table 52. Aleva Neurotherapeutics SA Business Overview
Table 53. Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Product
Table 54. Aleva Neurotherapeutics SA Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 55. Aleva Neurotherapeutics SA Recent Development
Table 56. Beijing PINS Medical Co Company Detail
Table 57. Beijing PINS Medical Co Business Overview
Table 58. Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Product
Table 59. Beijing PINS Medical Co Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 60. Beijing PINS Medical Co Recent Development
Table 61. Boston Scientific Corporation Company Detail
Table 62. Boston Scientific Corporation Business Overview
Table 63. Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Product
Table 64. Boston Scientific Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 65. Boston Scientific Corporation Recent Development
Table 66. Functional Neuromodulation Ltd Company Detail
Table 67. Functional Neuromodulation Ltd Business Overview
Table 68. Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Product
Table 69. Functional Neuromodulation Ltd Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 70. Functional Neuromodulation Ltd Recent Development
Table 71. Medtronic Company Detail
Table 72. Medtronic Business Overview
Table 73. Medtronic Deep Brain Stimulation in Parkinson's Disease Product
Table 74. Medtronic Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. Neuronetics Inc. Company Detail
Table 77. Neuronetics Inc. Business Overview
Table 78. Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Product
Table 79. Neuronetics Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 80. Neuronetics Inc. Recent Development
Table 81. NeuroPace Inc. Company Detail
Table 82. NeuroPace Inc. Business Overview
Table 83. NeuroPace Inc. Deep Brain Stimulation in Parkinson's Disease Product
Table 84. NeuroPace Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 85. NeuroPace Inc. Recent Development
Table 86. Nevro Corporation Company Detail
Table 87. Nevro Corporation Business Overview
Table 88. Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Product
Table 89. Nevro Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024) & (US$ Million)
Table 90. Nevro Corporation Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deep Brain Stimulation in Parkinson's Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Type: 2023 VS 2030
Figure 3. Dual Channel Deep brain Stimulator Features
Figure 4. Single Channel Deep brain Stimulator Features
Figure 5. Global Deep Brain Stimulation in Parkinson's Disease Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Neurology Clinics Case Studies
Figure 9. Research Centers Case Studies
Figure 10. Deep Brain Stimulation in Parkinson's Disease Report Years Considered
Figure 11. Global Deep Brain Stimulation in Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Deep Brain Stimulation in Parkinson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Region: 2023 VS 2030
Figure 14. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Players in 2023
Figure 15. Global Top Deep Brain Stimulation in Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deep Brain Stimulation in Parkinson's Disease as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Deep Brain Stimulation in Parkinson's Disease Revenue in 2023
Figure 17. North America Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2019-2030)
Figure 19. United States Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2019-2030)
Figure 23. Germany Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Share by Region (2019-2030)
Figure 31. China Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2019-2030)
Figure 39. Mexico Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2019-2030)
Figure 43. Turkey Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 46. Aleva Neurotherapeutics SA Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 47. Beijing PINS Medical Co Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 48. Boston Scientific Corporation Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 49. Functional Neuromodulation Ltd Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 50. Medtronic Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 51. Neuronetics Inc. Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 52. NeuroPace Inc. Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 53. Nevro Corporation Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
